Ahmed Mohamed Abdelsalam

Mr. Ahmed Mohamed Abdelsalam

University of Marburg

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
Ahmed SomaidaAhmed Somaida
Ahmed Somaida
AAAbdallah Mohamed Ayoub
Abdallah Mohamed Ayoub
FAFahd M. Alsharif
Fahd M. Alsharif
Eduard PreisEduard Preis
Eduard Preis
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Plant-derived proteins have emerged as leading candidates in several drug and food delivery applications in diverse pharmaceutical designs. Zein is considered one of the primary plant proteins obtained from maize, and is well known for its biocompatibility and safety in biomedical fields. The ability of zein to carry various pharmaceutically active substances (PAS) position it as a valuable contender for several in vitro and in vivo applications. The unique structure and possibility of surface covering with distinct coating shells or even surface chemical modifications have enabled zein utilization in active targeted and site-specific drug delivery. This work summarizes up-to-date studies on zein formulation technology based on its structural features. Additionally, the multiple applications of zein, including drug delivery, cellular imaging, and tissue engineering, are discussed with a focus on zein-based active targeted delivery systems and antigenic response to its potential in vivo applicability.

31 October 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Ahmed SomaidaAhmed Somaida
Ahmed Somaida
Imran TariqImran Tariq
Imran Tariq
GAGhazala Ambreen
Ghazala Ambreen
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
AAAbdallah Mohamed Ayoub
Abdallah Mohamed Ayoub
Udo BakowskyUdo Bakowsky
Udo Bakowsky
In this study, the potential cytotoxicity of four plant extracts originated from Cameroon: Xylopia aethiopica (XA), Imperata cylindrica (IC), Echinops giganteus (EG) and Dorstenia psilurus (DP) were examined in vitro. We tested the anti-proliferative activity of the methanolic extracts of these compounds using MTT assay on seven different human cancer cell lines: HeLa, MDA-MB-231, A549, HepG2, U-87, SK-OV-3 and HL60. Induction of cell death was assessed by cell cycle analysis, apoptosis was determined by Annexin V-FITC binding and caspase 3/7 activity. As well, changes in mitochondrial membrane potential (MMP) and cell migration were tested. The genetic toxicity, using the alkaline comet assay, was evaluated. The studied extracts inhibited the cell proliferation of all tested cancer cell lines with concentration dependent effect over time. All of these extracts mainly induced apoptosis of HeLa cells by the accumulation of hypodiploid cells in the sub-G0/G1 phase and increasing the activity of caspase 3/7, as well they showed potential MMP disturbance and expressed a marked inhibitory effect on cell migration. Assessment of probable genetic toxicity by these extracts revealed no or minimum incidence of genetic toxicity. Therefore, the studied plant extracts are exhibiting potent anticancer activity based upon marked induction of tumor-cell death.

4 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAbdallah Mohamed Ayoub
Abdallah Mohamed Ayoub
BGBernd Gutberlet
Bernd Gutberlet
Eduard PreisEduard Preis
Eduard Preis
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
ADAlice Abu Dayyih
Alice Abu Dayyih
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Multidrug resistance in pathogenic bacteria has become a significant public health concern. As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment. Parietin (PTN), also termed physcion, a natural anthraquinone, is a promising photosensitizer somewhat underrepresented in aPDT because of its poor water solubility and potential to aggregate in the biological environment. This study investigated whether the complexation of PTN with (2-hydroxypropyl)-β-cyclodextrin (HP-β-CD) could increase its solubility, enhance its photophysical properties, and improve its phototoxicity against bacteria. At first, the solubilization behavior and complexation constant of the PTN/HP-β-CD inclusion complexes were evaluated by the phase solubility method. Then, the formation and physicochemical properties of PTN/HP-β-CD complexes were analyzed and confirmed in various ways. At the same time, the photodynamic activity was assessed by the uric acid method. The blue light-mediated photodegradation of PTN in its free and complexed forms were compared. Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-β-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively. Overall, the low solubility, aggregation potential, and photoinstability of PTN were overcome by its complexation in HP-β-CD, potentially opening up new opportunities for treating infections caused by multidrug-resistant bacteria.

8 July 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AAAbdallah M. Ayoub
Abdallah M. Ayoub
MAMuhammed S. Atya
Muhammed S. Atya
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
JSJan Schulze
Jan Schulze
MAMuhammad U. Amin
Muhammad U. Amin
Eduard PreisEduard Preis
Eduard Preis

14 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
ABAmir Balash
Amir Balash
SKShaimaa Khedr
Shaimaa Khedr
MAMuhammad Umair Amin
Muhammad Umair Amin
KEKonrad H. Engelhardt
Konrad H. Engelhardt
Udo BakowskyUdo Bakowsky
Udo Bakowsky
Background: Photodynamic therapy (PDT) has evolved as a reliable therapeutic modality for cancer. However, the broad application of the technique is still limited because of poor bioavailability and the non-selective distribution of photosensitizers within host tissues. Herein, zein, a natural corn protein, was functionalized with glycyrrhetinic acid (GA) and polyethylene glycol (Z-PEG-GA) as a targeting platform for liver cancer cells. Parietin, as novel photosensitizer, was successfully encapsulated into zein via nanoprecipitation and used for the therapy of hepatocellular carcinoma. Methods: The in vitro phototoxicity of Z-PEG-GA nanoparticles and their non-functionalized control (Z-PEG) were assessed against hepatocellular carcinoma (HepG2 cells) and the In vivo biodistribution was determined in an adult male CD-1 Swiss albino mice model. Results: The formulated Z-PEG and Z-PEG-GA showed spherical shapes with average sizes of 82.8 and 94.7 nm for unloaded nanoparticles, respectively, and 109.7 and 111.5 nm for loaded nanoparticles carrying more than 70% of parietin, and Quantum yield measurements show that parietin’s photodynamic potential is conserved. Moreover, parietin-loaded Z-PEG-GA exhibited three-fold higher toxicity against liver cancer cells than its non-functionalized control and attained more than an eleven-fold enhancement in the generated intracellular reactive oxygen species (ROS) at a 9 J/cm2 radiant exposure. The generated intracellular ROS led to mitochondrial disruption and the release of cytochrome c. In vivo biodistribution studies revealed that fluorescence signals of Z-PEG-GA can persist in the excised animal liver for up to 24 h post-administration. Conclusions: Consequently, tailored zein can hold great potential for delivering several hydrophobic photosensitizers in anticancer PDT.

30 April 2026 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
Ahmed SomaidaAhmed Somaida
Ahmed Somaida
AAAhmed Mohamed Abdelsalam
Ahmed Mohamed Abdelsalam
SMSafwat Mariey
Safwat Mariey
MSmohamed sabry
mohamed sabry
MAMohammed A. Amin
Mohammed A. Amin
Majid M. Al-SawahliMajid M. Al-Sawahli
Majid M. Al-Sawahli